Motivation: Identification of rodent carcinogens is an important task in risk assessment of chemicals. SAR methods were proposed to reduce the number of animal experiments. Most of these methods ignore information about organ-specificity of tumorigenesis. Our study was aimed at the creation of classification models and a freely available online service for prediction of rodent carcinogens considering the species (rats, mice), sex and tissue-specificity from structural formula of compounds. Results: The data from Carcinogenic Potency Database for 1011 organic compounds evaluated on the standard two-year rodent carcinogenicity bioassay was used for the creation of training sets. Structure-activity relationships models for prediction of rodent organ-specific carcinogenicity were created by PASS software, which was based on Bayesian-like approach and Multilevel Neighborhoods of Atoms descriptors. The average prediction accuracy for training sets calculated by leave-one-out and 10-fold cross-validation was 79 and 78.2%, respectively. Availability and implementation: Freely available on the web at http://www.way2drug.com/ROSC.
Introduction
The evaluation of the carcinogenic potential of chemicals is an important task in drug discovery and ecotoxicological risk assessment (Huff et al., 2008) . Experimental testing of chemicals has been performed in two-year rodent carcinogenicity assay for the last 40 years (National Toxicology Program, 1977) . These studies are timeconsuming, rather expensive and they are criticized for ethical reasons (Madia et al., 2016) . Many different short-term experimental methods for prediction of long-term carcinogenicity were proposed to reduce the experimental costs. The study executed by the Center for Drug Evaluation and Research (CDER)/FDA showed that, in general, the accuracy of short-term studies was not sufficient to reduce the number of two-year rodent carcinogenicity assay (Bourcier et al., 2015) . There are no validated and regulatory accepted in vitro methods for carcinogenicity assessment (Madia et al., 2016) .
Nevertheless, several successful studies were made for prediction of long-term tissue-specific carcinogenicity using short-term bioassays (Benigni et al., 2013) or toxicogenomics data (Pérez et al., 2016) . In silico study of structure-activity relationships (SAR) for prediction of carcinogenicity has also been used for over thirty years along with short-term bioassays (Rusyn et al., 2012) . Usually SAR-based prediction of carcinogenicity for both congeneric and non-congeneric sets of chemicals disregards the organ specificity of tumorigenic effects (Bourcier et al., 2015) . The studies directed on the SAR modeling for rodent organ-specific carcinogenicity have not yet been performed. Some local SAR models revealed the reasonable accuracy of general carcinogenicity predictions for congeneric sets. However, such models have several practical limitations (Bourcier et al., 2015) . Non-congeneric sets include chemicals with diverse structures and different mechanisms of action. Therefore, it was Bioinformatics, 34(4), 2018, 710-712 doi: 10.1093/bioinformatics/btx678 Advance Access Publication Date: 23 October 2017
Applications Note difficult to create SAR models for such sets. This is the reason of low accuracy of prediction by global SAR models (Zhang et al., 2017) . On the other side, it is known that many carcinogens have species, sex and organ specificity and may be grouped according to these characteristics (Nishikawa, 2013) . That may be related to mechanisms of carcinogenic action, peculiarities of gene expression and cell-cycle regulations in different tissues as well as different pharmacokinetic properties of the studied compounds. In such case, the set contains non-congeneric compounds from the chemical structure point of view; however, they could be similar by the specificity of tumor manifestation. The feasibility of carcinogenetic organ specificity prediction is necessary for prioritization of testing, revealing the mode(s) of action and risk assessment. Earlier, we have demonstrated the ability of computer program PASS (Prediction of Activity Spectra for Substances) for prediction of general rodent carcinogenicity with the reasonable accuracy (Lagunin et al., 2005 (Lagunin et al., , 2009 . The aim of this study is to create SAR models and a freely available web-service for prediction of rodent organ-specific carcinogenicity, using the data from Carcinogenic Potency Database (CPDB) as the training sets.
Materials and methods
The CPDB data were extracted from EPA Distributed StructureSearchable Toxicity (DSSTox) Public Database Network (ftp://ftp. epa.gov/dsstoxftp/DSSTox_Archive_20150930/CPDBAS_Download Files/). Small inorganic compounds (e.g. NO 2 ), oils, paraffins and mixtures of compounds were excluded. The non-congeneric data for the 1011 compounds tested in the standard two-year rodent carcinogenicity bioassay given were used for the PASS training (see Supplementary Material). The number of carcinogens for each organ is represented in Supplementary Material. An organ specific carcinogenicity related with species and sex of animals is considered as a particular type of biological activity describing the action of the compound.
PASS was developed for prediction of the biological activity spectra for drug-like organic molecules on the basis of their structural formulae (Poroikov et al., 2000) . Biological activity spectrum is a list of biological activities with calculated probabilities of belonging to the classes of 'actives' (Pa) and 'inactives' (Pi). It is proposed that only those activities whose Pa value exceeds Pi value can be considered as reasonable. PASS is based on Bayesian approach and Multilevel Neighborhoods of Atoms (MNA) descriptors (e.g. Poroikov et al., 2000) . The prediction of PASS is based on the Structure-Activity Relationships database, which accumulates the results of the training set analysis. A freely available web-service was earlier developed (http://way2drug.com/PASSonline) to predict the biological activity spectra for chemicals (Lagunin et al., 2000) . The description of PASS algorithm is represented in Supplementary Material.
Results
After PASS training, we selected the activities with more than two carcinogens and the value of Area Under Curve (AUC), calculated by leave-one-out cross-validation (LOO CV) procedure) more than 0.65. The average AUC was 79%. A ten-fold cross-validation (10-fold CV) procedure was also used (the average AUC was 78.2%). The small difference between them displays the robustness of prediction results. The percent of new MNA descriptors for a tested molecule is used for assessment of the applicability domain: the more the percent of new MNA descriptors, the less the molecule structure is appropriate for the model. The tested molecules with up to 25% of new MNA descriptors are in the applicability domain.
The web-service uses MOL file, Marvin SJ applet or SMILES as input data for the structure of the test compound. The prediction results can be saved as SDF (Structure Data File), PDF or CSV files.
The results predicted for pioglitazone, which was excluded from the training set, showed that pioglitazone probably can be a urinary bladder carcinogen for male mice (see Supplementary Material). It was also confirmed for human in the clinical study (Tuccori et al., 2016) .
The International Agency for Research on Cancer (IARC) recommends taking into consideration the experimental data on animal species, sex and organ specificity of tumors for risk assessment (Nielsen et al. ,2008) , therefore, the created web-service is useful for carcinogenicity evaluation. Obviously, the compounds inducing tumor in multiple tissues and/or in different species may be more harmful to human as well. The difference between rodents and human in anatomy, physiology and metabolism is well known. Several rodent organs (e.g. Zymbal's gland, harderian gland, prepitual and clitoral gland) are absent in human. It is considered that tumors induced by a genotoxic mechanism are relevant for humans even if they are observed in tissue without direct human equivalent (Nielsen et al., 2008) . The prediction results of such organ-specific non-genotoxic carcinogens are difficult to extrapolate on human and may be considered as insignificant (Omenn, 2001 ). Thus, prediction of organ-specific carcinogenicity helps investigators in prioritization of experiments, selection of appropriate short-time carcinogenicity assays, design of safety drugs and understanding the nature of chemical carcinogenicity (ability of carcinogens to permeation and/or accumulation in an appropriate tissue).
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